: Dana Farber Cancer Institute — Boston, Massachusetts

: Dana Farber Cancer Institute is a clinical research site located in Boston, Massachusetts, United States 02115.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

: Dana Farber Cancer Institute has participated in 1 clinical trials.

Therapeutic areas: Pigmented Villonodular Synovitis, Giant Cell Tumors of the Tendon Sheath, Tenosynovial Giant Cell Tumor.

Sponsors: Daiichi Sankyo.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for : Dana Farber Cancer Institute?

: Dana Farber Cancer Institute has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has : Dana Farber Cancer Institute conducted?

: Dana Farber Cancer Institute has 1 clinical trials on record. Their work covers Pigmented Villonodular Synovitis, Giant Cell Tumors of the Tendon Sheath, Tenosynovial Giant Cell Tumor.

Is : Dana Farber Cancer Institute accredited by Crixeo Health?

: Dana Farber Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about : Dana Farber Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.